Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA-Reference-Cited by-同舟云学术

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA

Published:2010-12-09 Issue:2 Volume:27 Page:315-325
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Smolen Josef S.,Boers Maarten,Abadie Eric C.,Breedveld Ferdinand C.,Emery Paul,Bardin Thomas,Goel Niti,Ethgen Dominique J.,Avouac Bernard P.,Dere Willard H.,Durez Patrick,Matucci-Cerinic Marco,Flamion Bruno,Laslop Andrea,Lekkerkerker Frits J.,Miossec Pierre,Mitlak Bruce H.,Ormarsdóttir Sif,Paolozzi Laurence,Rao Ravi,Reiter Susan,Tsouderos Yannis,Reginster Jean-Yves

Publisher

Informa Healthcare

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1185/03007995.2010.542135

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease activity affects the recurrent deformities of the lesser toes after resection arthroplasty for rheumatoid forefoot deformity;Modern Rheumatology;2020-07-06

2. A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial;Arthritis Research & Therapy;2017-09-29

3. Review of head-to-head study designs in rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2016-12

4. Gold nanoparticles: A critical review of therapeutic applications and toxicological aspects;Journal of Toxicology and Environmental Health, Part B;2016-05-18

5. Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease;Annals of the Rheumatic Diseases;2016-04-01